Literature DB >> 6368762

The current status of therapy for and prevention of blast crisis of chronic myelocytic leukemia.

P H Wiernik.   

Abstract

Entities:  

Mesh:

Year:  1984        PMID: 6368762     DOI: 10.1200/JCO.1984.2.4.329

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Therapy of the myeloid blast phase of chronic granulocytic leukemia with plicamycin and hydroxyurea.

Authors:  L H Trümper; A D Ho; W Hunstein; H van der Lelie; R Goudsmit
Journal:  Blut       Date:  1989-02

Review 2.  Chronic myelogenous leukemia of childhood.

Authors:  K L Saving
Journal:  Indian J Pediatr       Date:  1987 Nov-Dec       Impact factor: 1.967

3.  A pilot study of carboplatin and mitoxantrone in blast crisis of chronic myeloid leukemia.

Authors:  Janice P Dutcher; Evelyn L Morris; Bruce Gaynor; Elisabeth Paietta; Peter H Wiernik
Journal:  Med Oncol       Date:  2009-08-21       Impact factor: 3.064

Review 4.  Accelerated and blastic phase of chronic myeloid leukemia.

Authors:  J P Dutcher; P H Wiernik
Journal:  Curr Treat Options Oncol       Date:  2000-04

5.  Treatment of acute myeloid leukemia and blastic phase of chronic myeloid leukemia with combined eflornithine (alpha difluoromethylornithine) and methylglyoxal-bis-guanyl hydrazone (methyl-GAG).

Authors:  J A Gastaut; G Tell; P J Schechter; D Maraninchi; B Mascret; Y Carcassonne
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.